**Abstract**

**Objective:** Induction of the BMP/RA-induced neural specific protein-1 (BRINP1) gene begins in the mouse nervous system from the early developmental stages, and it is highly expressed in various brain regions in adulthood. Studies have demonstrated that epileptic patients tend to have comorbid similar psychiatric symptoms to attention deficient hyperactivity disorder and autistic patients. In this study, the physiological role of BRINP1 was evaluated by conducting behavioral pharmacological tests in kindled BRINP1-deficient (KO) mice. Using immunohistochemistry, c-Fos expression levels in kindled mice were also studied.

**Methods:** To induce kindling, mice were intraperitoneally injected with pentylenetetrazol at a dose of 35 mg/kg once every 48 h. After the final challenge, mice were tested.

**Results:** The development of kindled convulsions was not significantly different between wild-type and BRINP1-KO mice. BRINP1-KO mice showed less anxiety-like behavior than wild-type mice and the induction of kindling reduced anxiety-like behavior in both genotypes in the elevated plus maze test. In addition, c-Fos expression at steady state was significantly increased in the dentate gyrus of KO-kindled mice compared with wild-type mice. Furthermore, c-Fos expression was increased in the hippocampus, amygdala, and hypothalamus in both kindled and KO-kindled mice at 3 hours after pentylenetetrazol injection, although this increase was similar in KO and wild-type mice.

**Conclusion:** These findings suggest that the BRINP1 gene is not directly involved in the epileptic behavior of kindling convulsions. However, elevated c-Fos expression in dentate granule neurons in BRINP1-KO mice at steady state implicated that BRINP1 involves regulation of neuronal excitability which is responsible for preventing onset of behavioral psychiatric symptoms.
